Amyloidosis is a rare but serious condition characterized by the abnormal buildup of amyloid proteins in various organs, including the liver. This accumulation can interfere with normal organ function and lead to abnormal liver function tests (LFTs). Understanding how amyloidosis affects the liver is important for early diagnosis and management.

What Is Amyloidosis?

Amyloidosis involves the deposition of amyloid, a misfolded protein, in tissues and organs. There are different types of amyloidosis, such as AL amyloidosis, which is related to plasma cell disorders, and AA amyloidosis, associated with chronic inflammatory conditions. When amyloid deposits accumulate in the liver, they can disrupt its normal functions.

How Amyloidosis Affects the Liver

In amyloidosis, amyloid proteins deposit in the liver's extracellular space. This buildup can cause the liver to enlarge (hepatomegaly) and impair its ability to perform essential functions like protein synthesis, detoxification, and bile production. The extent of liver involvement varies depending on the severity of amyloid deposition.

Impact on Liver Function Tests

Abnormal liver function tests in amyloidosis typically include:

  • Elevated alkaline phosphatase (ALP): Indicates cholestasis or bile flow obstruction.
  • Increased liver enzymes (ALT and AST): Suggest hepatocellular injury.
  • Low serum albumin: Reflects decreased protein synthesis.
  • Prolonged prothrombin time (PT): Signifies impaired clotting factor production.

These abnormalities can mimic other liver diseases, making diagnosis challenging. Liver biopsies revealing amyloid deposits confirm amyloidosis as the cause.

Clinical Significance

Monitoring liver function tests in patients with known amyloidosis helps assess disease progression and organ involvement. Treatment strategies aim to reduce amyloid production and deposition, which may improve liver function and overall prognosis.

Conclusion

Amyloidosis can significantly impact liver health, leading to abnormal liver function tests. Awareness of this connection is vital for early diagnosis and appropriate management. If amyloidosis is suspected, a combination of laboratory tests and tissue biopsies is essential for confirmation and guiding treatment decisions.